ARN Physician Featured in: American Rheumatology Network Promotes a Biosimilar Pathway
The American Rheumatology Network (ARN) has been so successful with cost management, particularly via the use of biosimilars, that it believes its model is worthy of emulation, said Colin C. Edgerton, MD, executive chairman of ARN, who spoke on the subject recently in an Academy of Managed Care Pharmacy–sponsored webinar. “Certainly, rheumatologists are eager to […]
ARN Physician Featured in: American Rheumatology Network Promotes a Biosimilar Pathway Read More »
